Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-067908
Filing Date
2025-03-31
Accepted
2025-03-31 08:40:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 d939122d424b3.htm 424B3 22361
2 GRAPHIC g939120dsp4.jpg GRAPHIC 10306
3 GRAPHIC g939122g0317152830568.jpg GRAPHIC 3481
  Complete submission text file 0001193125-25-067908.txt   37430
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-284606 | Film No.: 25789107
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)